Literature DB >> 15548357

Gene expression profiling of mouse teratocarcinomas uncovers epigenetic changes associated with the transformation of mouse embryonic stem cells.

Allison E Bonner1, Yian Wang, Ming You.   

Abstract

The molecular mechanisms of the development of teratocarcinomas from stem cells are largely unknown. To determine which genes are associated with the transformation of these cells, we have performed oligonucleotide microarray analysis, using Affymetrix U74A GeneChips, on both cell cultures and tumors in nude mice. We identified 68 genes that significantly differed in expression between the ES cell culture and the teratocarcinoma cell line, SCC-PSA1, and 51 genes with statistically different expression patterns between the ES cell tumors and the teratocarcinomas (P < .00005). We found that there were 20 genes that had common expression patterns in both groups. We also examined the role of the transition from in vitro to in vivo by comparing ES cell culture to ES cell tumor, and teratocarcinoma cell line to teratocarcinomas. We identified 22 genes that were upregulated in the ES cell tumors and 42 that had a decreased expression in the tumor (P < .0001). In comparing SCC-PSA1 to its tumor, we identified 34 upregulated genes and 25 downregulated genes (P < .001). There were only 10 genes in common from these two lists. GenMapp search revealed that several pathways, especially the cell cycle pathway, are actively involved in the induction of teratocarcinomas. Our results indicate that many key development genes may play a key role in the transformation of ES cells into teratocarcinoma cells.

Entities:  

Mesh:

Year:  2004        PMID: 15548357      PMCID: PMC1531652          DOI: 10.1593/neo.04124

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  14 in total

1.  Induction of disabled-2 gene during megakaryocyte differentiation of k562 cells.

Authors:  C P Tseng; C H Huang; C C Tseng; M H Lin; J T Hsieh; C H Tseng
Journal:  Biochem Biophys Res Commun       Date:  2001-07-06       Impact factor: 3.575

2.  Synthesis and functional analyses of nuclear clusterin, a cell death protein.

Authors:  Konstantin S Leskov; Dmitry Y Klokov; Jing Li; Timothy J Kinsella; David A Boothman
Journal:  J Biol Chem       Date:  2003-01-24       Impact factor: 5.157

3.  The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos.

Authors:  L C Stevens
Journal:  Dev Biol       Date:  1970-03       Impact factor: 3.582

Review 4.  Teratocarcinomas and other neoplasms as developmental defects in gene expression.

Authors:  B Mintz; R A Fleischman
Journal:  Adv Cancer Res       Date:  1981       Impact factor: 6.242

5.  Theoretical and experimental comparisons of gene expression indexes for oligonucleotide arrays.

Authors:  William J Lemon; Jeffrey J T Palatini; Ralf Krahe; Fred A Wright
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

6.  Genome-wide expression monitoring in Saccharomyces cerevisiae.

Authors:  L Wodicka; H Dong; M Mittmann; M H Ho; D J Lockhart
Journal:  Nat Biotechnol       Date:  1997-12       Impact factor: 54.908

7.  Clusterin mRNA expression in apoptotic and activated rat thymocytes.

Authors:  Jung-Hyun Park; Jee-Sun Park; Sung-Kyu Ju; Kwan-Bok Lee; Yoo-Kyoung Park; Myung-Hee Kang; Shin-Young Na; Kwan-Hee You
Journal:  Cell Res       Date:  2003-02       Impact factor: 25.617

8.  Expression monitoring by hybridization to high-density oligonucleotide arrays.

Authors:  D J Lockhart; H Dong; M C Byrne; M T Follettie; M V Gallo; M S Chee; M Mittmann; C Wang; M Kobayashi; H Horton; E L Brown
Journal:  Nat Biotechnol       Date:  1996-12       Impact factor: 54.908

9.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.

Authors:  C Li; W H Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

Review 10.  The Cdc7/Dbf4 protein kinase: target of the S phase checkpoint?

Authors:  P Jares; A Donaldson; J J Blow
Journal:  EMBO Rep       Date:  2000-10       Impact factor: 8.807

View more
  6 in total

Review 1.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

2.  Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth.

Authors:  Qiang Li; Mark E O'Malley; David L Bartlett; Z Sheng Guo
Journal:  Mol Cancer       Date:  2011-05-24       Impact factor: 27.401

3.  RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts.

Authors:  Flora Iovino; Laura Lentini; Angela Amato; Aldo Di Leonardo
Journal:  Mol Cancer       Date:  2006-09-20       Impact factor: 27.401

Review 4.  The impact of stem cells in neuro-oncology: applications, evidence, limitations and challenges.

Authors:  Sabino Luzzi; Alice Giotta Lucifero; Ilaria Brambilla; Chiara Trabatti; Mario Mosconi; Salvatore Savasta; Thomas Foiadelli
Journal:  Acta Biomed       Date:  2020-06-30

5.  cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.

Authors:  Ying-Lei Wang; Ying-Ying Zhang
Journal:  Biomed Res Int       Date:  2020-12-17       Impact factor: 3.411

6.  Establishment of mouse teratocarcinomas stem cells line and screening genes responsible for malignancy.

Authors:  Tao Liu; Ying Wang; Xinrong Peng; Liqing Zhang; Jingbo Cheng; Huajun Jin; Mengchao Wu; Qijun Qian
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.